Dendritic cells (DCs) are a type of an antigen-presenting cell which undertake a job on
capturing antigens coming from pathogens or tumors and presenting to T cells for immune …

Simple Summary This review summarizes the evidence from clinical trials and recent
preclinical studies regarding the evaluation and optimization of dendritic cells (DCs)-based …

Background Breast cancer is a highly heterogeneous disease, this poses challenges for
classification and management. Long non-coding RNAs play acrucial role in the breast …

Hepatocellular carcinoma (HCC) causes a significant health burden globally and its impact
is expected to increase in the coming years. Intermediate stage HCC, as defined by the …

Liver cancer is one of the most common malignant tumors, with limited treatment and 8.2%
mortality. Liver cancer is the fourth leading cause of cancer-related deaths, which seriously …

Introduction Camrelizumab (also known as SHR-1210), a humanized monoclonal antibody
against PD-1, has been shown to block the binding of PD-1 to PD-L1 and consequently …

Background Acid phosphatase type 6 (ACP6) is a mitochondrial lipid phosphate
phosphatase that played a role in regulating lipid metabolism and there is still blank in the …

Dendritic cells (DCs) are the most potent antigen-presenting cells in the human body. They
detect and process environmental signals and communicate with T cells to bridge innate …

The use of oncolytic viruses has become an attractive tool in the clinics for the treatment of
various tumor types. Such viruses are genetically modified to conditionally replicate in …

Introduction Although many approaches have been used to treat hepatocellular carcinoma
(HCC), the clinical benefits were limited, particularly for advanced HCC. However, recent …